Chordoma: an update on the pathophysiology and molecular mechanisms.

Abstract

Chordoma is a rare low-grade primary malignant skeletal tumor, which is presumed to derive from notochord remnants. The pathogenesis of chordoma has not been fully elucidated. However, recent advances in the molecular biology studies have identified brachyury underlying the initiation and progression of chordoma cells. More efforts have been made on accumulating evidence of the notochordal origin of chordoma, discovering signaling pathways and identifying crucial targets in chordomagenesis. In this review, we summarize the most recent research findings and focus on the pathophysiology and molecular mechanisms of chordoma.

• Authors: Xin Sun, Francis Hornicek, Joseph H Schwab
• Journal: Current reviews in musculoskeletal medicine (Curr Rev Musculoskelet Med) Vol. 8 Issue 4 Pg. 344-52 (Dec 2015) ISSN: 1935-973X [Print] United States
• PMID: 26493697 (Publication Type: Journal Article)